{"abstract":"The National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to Kite Pharma, Inc. (\"Kite\") located in Santa Monica, CA to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/10/05/2016-24030.html","cfr_references":[],"citation":"81 FR 69066","comment_url":null,"comments_close_on":"2016-10-20","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NCI Technology Transfer Center on or before October 20, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2016-24030","effective_on":null,"end_page":69067,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/10/05/2016-24030.xml","html_url":"https://www.federalregister.gov/documents/2016/10/05/2016-24030/prospective-grant-of-exclusive-patent-license-development-of-anti-cd70-chimeric-antigen-receptors","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-24030?publication_date=2016-10-05","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-10-05/2016-24030/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":545,"last_updated":"2026-10-24 06:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-10-05/pdf/2016-24030.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-24030.pdf?1475585149","publication_date":"2016-10-05","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/10/05/2016-24030.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T20:57:49Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":69066,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Development of Anti-CD70 Chimeric Antigen Receptors for the Treatment of CD70 Expressing Cancers","toc_doc":"Development of Anti-CD70 Chimeric Antigen Receptors for the Treatment of CD70 Expressing Cancers","toc_subject":"Proposed Exclusive Patent License:","topics":[],"type":"Notice","volume":81}